Cobry E, Reznick-Lipina T, Pyle L, Slover RJ, Thomas JF, Alonso GT, Wadwa RP. Diabetes Technology Use in Remote Pediatric Patients with Type 1 Diabetes Using Clinic-to-Clinic Telemedicine. Diabetes Technol Ther. 2021 Sep 15. [Epub ahead of print] PubMed PMID: 34524007
Akturk HK, Snell-Bergeon J, Pyle L, Fivekiller E, Garg S, Cobry E. Accuracy of a breath ketone analyzer to detect ketosis in adults and children with type 1 diabetes. J Diabetes Complications. 2021 Aug 27;:108030. [Epub ahead of print] PubMed PMID: 34481712
Messer LH, Berget C, Pyle L, Vigers T, Cobry E, Driscoll KA, Forlenza GP. Real-World Use of a New Hybrid Closed Loop Improves Glycemic Control in Youth with Type 1 Diabetes. Diabetes Technol Ther. 2021 Jun 21. [Epub ahead of print] PubMed PMID: 34096789
Schoelwer MJ, Kanapka LG, Wadwa RP, Breton MD, Ruedy KJ, Ekhlaspour L, Forlenza GP, Cobry EC, Messer LH, Cengiz E, Jost E, Carria L, Emory E, Hsu LJ, Weinzimer SA, Buckingham BA, Lal RA, Oliveri MC, Kollman CC, Dokken BB, Cherñavvsky DR, Beck RW, DeBoer MD. Predictors of Time-in-Range (70-180?mg/dL) Achieved Using a Closed-Loop Control System. Diabetes Technol Ther. 2021 Jul;23(7):475-481. PubMed PMID: 33689454
Cobry EC, Kanapka LG, Cengiz E, Carria L, Ekhlaspour L, Buckingham BA, Hood KK, Hsu LJ, Messer LH, Schoelwer MJ, Emory E, Ruedy KJ, Beck RW, Wadwa RP, Gonder-Frederick L. Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control. Diabetes Technol Ther. 2021 Jun;23(6):401-409. PubMed PMID: 33404325
Forlenza GP, Buckingham BA, Brown SA, Bode BW, Levy CJ, Criego AB, Wadwa RP, Cobry EC, Slover RJ, Messer LH, Berget C, McCoy S, Ekhlaspour L, Kingman RS, Voelmle MK, Boyd J, O'Malley G, Grieme A, Kivilaid K, Kleve K, Dumais B, Vienneau T, Huyett LM, Lee JB, O'Connor J, Benjamin E, Ly TT. First Outpatient Evaluation of a Tubeless Automated Insulin Delivery System with Customizable Glucose Targets in Children and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2021 Jun;23(6):410-424. PubMed PMID: 33325779
Cobry E, Pyle L, Vigers T, Meltzer L. Association Between COVID Exposure, Impact, and Distress and Pediatric Quality of Life in Youth with Type 1 Diabetes. ePoster presentation at the International Society for Pediatric and Adolescent Diabetes (ISPAD), Virtual Conference, October 2021.
Escobar E, Towers L, Berget C, Vigers T, Pyle L, Messer L, Cobry E, Slover R, Wadwa RP, Forlenza G. Fear of Hypoglycemia and System Expectation Outcomes Decrease in the First 6 Months of Control-IQ Use in a Clinical Population of Youth with Type 1 Diabetes. ePoster presentation at the International Society for Pediatric and Adolescent Diabetes (ISPAD), Virtual Conference, October 2021.
Cobry E, Vigers T, Pyle L, Meltzer L. Family Exposure and Impact of COVID-19 on a Pediatric T1D Population. ePoster presentation at the American Diabetes Association (ADA) Scientific Sessions, Virtual Conference, June 2021.
Karami A, Pyle L, Jost E, Wadwa RP, Meltzer L, Cobry E. Association of Glycemic Ranges and Sleep Measures in Youth with T1D and their Parents. ePoster presentation at the American Diabetes Association (ADA) Scientific Sessions, Virtual Conference, June 2021.
Cobry E, Karami A, Jost E, Pyle L, Meltzer L, Wadwa P. Initial Impact of the Transition to Tandem Control-IQ on Sleep in Youth with Type 1 Diabetes (T1D) and their Parents. ePoster presentation at the International Conference on Advanced Technologies and Treatment for Diabetes (ATTD), Virtual Conference, June 2021.
Cobry E, Hamburger E, Jaser S. Impact of the Hybrid Closed-Loop System on Sleep and Quality of Life in Youth with Type 1 Diabetes and their Parents. Diabetes Technol Ther. 2020 Mar 26. [Epub ahead of print] PubMed PMID: 32212971
Cobry EC, Berget C, Messer LH, Forlenza GP. Review of the Omnipod(®) 5 Automated Glucose Control System Powered by Horizon™ for the treatment of Type 1 diabetes. Ther Deliv. 2020 Aug;11(8):507-519. PubMed PMID: 32723002
Cobry E, Berget C, Messer L, Escobar E, Jost E, Dong F, Driscoll K, Forlenza G. Sleep Activity Mode Use in Pediatric Patients with Type 1 Diabetes Using Control-IQ. eposter presentation at International Society for pediatric and Adolescent Diabetes (ISPAD) Virtual Conference, October 2020.
Berget C, Messer L, Dong F, Escobar E, Jost E, Cobry E, Slover R, Driscoll K, Forlenza G. Increased Time in Range in the First Month of Control-IQ Use in a Clinical Sample of Youth with T1D. eposter presentation at International Society for Pediatric and Adolescent Diabetes (ISPAD) Virtual Conference, October 2020.
Boranian E, Messer L, Berget C, Cobry E, Wadwa R, Slover R, Forlenza G. Successes and Challenges with CGM in Children and Adolescents with T1D. eposter presentation at International Society for Pediatric and Adolescent Diabetes (ISPAD) Virtual Conference, October 2020.
Messer L, Berget C, Towers L, Otten B, Ernst A, Karami A, Thomas S, Cobry E, Alonso T, Slover R, Wadwa P, Forlenza G. Evaluation of a Control-IQ Follow-up Program by Diabetes Educators. eposter presentation at International Society for Pediatric and Adolescent Diabetes (ISPAD) Virtual Conference, October 2020.
Cobry E, Berget C, Messer L, Wadwa P, Vigers T, Pyle L, Slover R, Driscoll KA, Forlenza G. Nocturnal Alarms: A Potential Barrier to Diabetes Technology Use. ePoster presentation at American Diabetes Association (ADA) Virtual Conference, June 2020.
Cobry E, Reznick-Lipina T, Pyle L, Slover R, Thomas JF, Alonso GT, Wadwa RP. Lower Use of Technology in Youth with Type 1 Diabetes in Locations Distant from Specialty Care. ePoster presentation at American Diabetes Association (ADA) virtual conference, June 2020.
Cobry E, Berget C, Messer L, Wadwa RP, Driscoll KA, Pyle L, Vigers T, Forlenza G. Hypoglycemia Fear and Diabetes Distress: What We Have Learned From 1 Year of Hybrid Closed-Loop Therapy in Youth and Young Adults with Type 1 Diabetes. ePoster Oral Presentation at the International Conference on Advanced Technologies and Treatments for Diabetes (ATTD). Madrid, Spain. February 2020.
Cobry E, Kanapka L, Cengiz E, Carria L, Ekhlaspour L, Buckingham B, Hood K, Hsu L, Messer L, Schoelwer M, Emory E, Reudy K, Beck R, Wadwa RP, Gonder-Frederick L for the iDCL Trial Research Group. Health-Related Quality of Life and Treatment Satisfaction in Parents and Children with Type 1 Diabetes Using Closed-Loop Control. Under Review.
Cobry E, Reznick-Lipina T, Pyle L, Slover R, Thomas JF, Alonso T, Wadwa RP. Lower Diabetes Technology Use in Pediatric Patients with Type 1 Diabetes in Locations Distant from a Specialty Center. In Preparation.
Schoelwer M, Kanapka L, Wadwa RP, Breton M, Ruedy K, Ekhlaspour L, Forlenza G, Cobry E, Messer L, Cengiz E, Jost E, Carria L, Emory E, Hsu L, Weinzimer S, Buckingham B, Lal R, Oliveri M, Kollman C, Dokken B, Chernayvsky D, Beck R, DeBoer M for the iDCL Trial Research Group. Predictors of Time-In-Range (70-180mg/dl) Achieved Using a Closed-Loop Control System. In Preparation.
Pauley M, Tan S, Sikand G, Cobry E. Severe, Refractory Insulin Edema with Cardiopulmonary Congestion Requiring Multiple Treatment Modalities in an Adolescent with Known Type 1 Diabetes. Clinical Diabetes. In Press.
Cobry E, Bisio A, Wadwa RP, Breton M. Improvements in Parental Sleep, Fear of Hypoglycemia, and Diabetes Distress with the Use of an Advanced Hybrid Closed-Loop System. Diabetes Care Under Review with Revisions Requested.